Menu Search
Equities

FibroGen Inc

1FG:BER

FibroGen Inc

Actions
  • Price (EUR)0.3392
  • Today's Change-0.017 / -4.69%
  • Shares traded6.50k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024 20:40 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year FibroGen Inc grew revenues 4.99% from 140.73m to 147.75m. Additionally the company has reduced the cost of goods sold, selling, general and administrative expenses and debt expenses (all as percentages of sales). These changes narrowed profitability losses from -293.65m to -284.23m.
Gross margin76.65%
Net profit margin-98.60%
Operating margin-91.86%
Return on assets-42.40%
Return on equity--
Return on investment-89.79%
More ▼

Cash flow in USDView more

In 2023, cash reserves at FibroGen Inc fell by 42.01m. However, Cash Flow from Investing totalled 153.66m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 315.02m for operations while cash generated from financing totalled 122.75m.
Cash flow per share-1.67
Price/Cash flow per share--
Book value per share-2.31
Tangible book value per share-2.31
More ▼

Balance sheet in USDView more

FibroGen Inc uses little or no debt in its capital structure.
Current ratio1.41
Quick ratio1.24
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.